Hepatitis C virus-lipid interplay: pathogenesis and clinical impact
W Elgretli, T Chen, N Kronfli, G Sebastiani - Biomedicines, 2023 - mdpi.com
Hepatitis C virus (HCV) infection represents the major cause of chronic liver disease,
leading to a wide range of hepatic diseases, including cirrhosis and hepatocellular …
leading to a wide range of hepatic diseases, including cirrhosis and hepatocellular …
The emerging role of miRNA-122 in infectious diseases: Mechanisms and potential biomarkers
R Mirzaei, S Karampoor, NL Korotkova - Pathology-Research and Practice, 2023 - Elsevier
Abstract microRNAs (miRNAs) are small, non-coding RNA molecules that play crucial
regulatory roles in numerous cellular processes. Recent investigations have highlighted the …
regulatory roles in numerous cellular processes. Recent investigations have highlighted the …
Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma
Background MicroRNAs (miRNAs) play a crucial role in gene expression and regulation,
with dysregulation of miRNA function linked to various diseases, including hepatitis C virus …
with dysregulation of miRNA function linked to various diseases, including hepatitis C virus …
Oncogenic viruses and host lipid metabolism: a new perspective
Z Gong, Z Yan, W Liu, B Luo - Journal of General Virology, 2023 - microbiologyresearch.org
As noncellular organisms, viruses do not have their own metabolism and rely on the
metabolism of host cells to provide energy and metabolic substances for their life cycles …
metabolism of host cells to provide energy and metabolic substances for their life cycles …
[PDF][PDF] Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. Biomedicines 2023, 11, 271
W Elgretli, T Chen, N Kronfli, G Sebastiani - 2023 - researchgate.net
Hepatitis C virus (HCV) infection represents the major cause of chronic liver disease,
leading to a wide range of hepatic diseases, including cirrhosis and hepatocellular …
leading to a wide range of hepatic diseases, including cirrhosis and hepatocellular …
Role of Mac-2-binding protein glycosylation isomer in assessment of liver fibrosis in patients with chronic hepatitis C virus receiving direct-acting antiviral agents
M Elkhayat, AE Lehleh, NT Aboelkhair… - Menoufia Medical …, 2023 - menoufia-med-j.com
Objectives We aimed to investigate the clinical usefulness of Mac-2-binding protein
glycosylation isomer (M2BPGi) in liver fibrosis assessment within patients with chronic …
glycosylation isomer (M2BPGi) in liver fibrosis assessment within patients with chronic …
[PDF][PDF] Hepatitis C-related liver-fibrosis regression after direct-acting antiviral therapy
MQ Malik - 2021 - figshare.mq.edu.au
Background: In low-and middle-income countries (LMICs), hepatitis C virus (HCV) treatment
uptake is increasing given availability of generic highly effective direct-acting antiviral (DAA) …
uptake is increasing given availability of generic highly effective direct-acting antiviral (DAA) …
[PDF][PDF] ОПТИМІЗАЦІЯ РАННЬОЇ ДІАГНОСТИКИ НЕАЛКОГОЛЬНОЇ ЖИРОВОЇ ХВОРОБИ ПЕЧІНКИ НА ТЛІ ОЖИРІННЯ ТА НАДЛИШКОВОЇ ВАГИ З …
НІ ЧЕРЕЛЮК - therapy.org.ua
АНОТАЦІЯ Черелюк НІ «Оптимізація ранньої діагностики неалкогольної жирової
хвороби печінки на тлі ожиріння та надлишкової ваги з урахуванням основних філотипів …
хвороби печінки на тлі ожиріння та надлишкової ваги з урахуванням основних філотипів …